دورية أكاديمية
أعرض في EDS

Green Synthesis of Silver Nanoparticles Using Jacobaea maritima and the Evaluation of Their Antibacterial and Anticancer Activities.

التفاصيل البيبلوغرافية
العنوان: Green Synthesis of Silver Nanoparticles Using Jacobaea maritima and the Evaluation of Their Antibacterial and Anticancer Activities.
المؤلفون: Althubiti AA; Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia., Alsudir SA; Bioengineering Institute, Health Sector, King Abdulaziz City for Science and Technology, Riyadh 11442, Saudi Arabia., Alfahad AJ; Institute of Waste Management and Recycling Technologies, Sustainability & Environment Sector, King Abdulaziz City for Science and Technology, Riyadh 11442, Saudi Arabia., Alshehri AA; Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia., Bakr AA; Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia., Alamer AA; Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia., Alrasheed RH; Institute of Refinery and Petrochemicals, Energy and Industry Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia., Tawfik EA; Advanced Diagnostics and Therapeutics Institute, Health Sector, King Abdulaziz City for Science and Technology (KACST), Riyadh 11442, Saudi Arabia.
المصدر: International journal of molecular sciences [Int J Mol Sci] 2023 Nov 20; Vol. 24 (22). Date of Electronic Publication: 2023 Nov 20.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, [2000-
مواضيع طبية MeSH: Metal Nanoparticles*/chemistry , Asteraceae*, Silver/chemistry ; Microbial Sensitivity Tests ; Spectroscopy, Fourier Transform Infrared ; Anti-Bacterial Agents/chemistry ; Plant Extracts/pharmacology ; Plant Extracts/chemistry ; Green Chemistry Technology/methods
مستخلص: Much attention has been gained on green silver nanoparticles (green-AgNPs) in the medical field due to their remarkable effects against multi-drug resistant (MDR) microorganisms and targeted cancer treatment. In the current study, we demonstrated a simple and environment-friendly (i.e., green) AgNP synthesis utilizing Jacobaea maritima aqueous leaf extract. This leaf is well-known for its medicinal properties and acts as a reducing and stabilizing agent. Nanoparticle preparation with the desired size and shape was controlled by distinct parameters; for instance, temperature, extract concentration of salt, and pH. The characterization of biosynthesized AgNPs was performed by the UV-spectroscopy technique, dynamic light scattering, scanning electron microscopy, X-ray diffraction, and Fourier-transform infrared. The successful formation of AgNPs was confirmed by a surface plasmon resonance at 422 nm using UV-visible spectroscopy and color change observation with a particle size of 37± 10 nm and a zeta potential of -10.9 ± 2.3 mV. SEM further confirmed the spherical size and shape of AgNPs with a size varying from 28 to 52 nm. Antibacterial activity of the AgNPs was confirmed against all Gram-negative and Gram-positive bacterial reference and MDR strains that were used in different inhibitory rates, and the highest effect was on the E-coli reference strain (MIC = 25 μg/mL). The anticancer study of AgNPs exhibited an IC 50 of 1.37 μg/mL and 1.98 μg/mL against MCF-7 (breast cancer cells) and A549 (lung cancer cells), respectively. Therefore, this green synthesis of AgNPs could have a potential clinical application, and further in vivo study is required to assess their safety and efficacy.
References: Nanomaterials (Basel). 2019 Nov 02;9(11):. (PMID: 31684041)
Pharmaceutics. 2022 May 21;14(5):. (PMID: 35631691)
Int J Nanomedicine. 2021 May 14;16:3343-3356. (PMID: 34017172)
Biomolecules. 2019 Oct 28;9(11):. (PMID: 31661912)
Environ Technol. 2022 Oct 17;:1-19. (PMID: 36170044)
3 Biotech. 2023 Sep;13(9):296. (PMID: 37564274)
Sci Rep. 2019 Oct 23;9(1):15212. (PMID: 31645616)
Nanomaterials (Basel). 2021 Apr 14;11(4):. (PMID: 33919801)
Ecotoxicol Environ Saf. 2016 Dec;134(Pt 2):467-473. (PMID: 27156649)
Nanomaterials (Basel). 2021 Feb 14;11(2):. (PMID: 33673018)
Nutrients. 2020 Feb 12;12(2):. (PMID: 32059369)
Nanomaterials (Basel). 2023 Jun 28;13(13):. (PMID: 37446480)
Microorganisms. 2023 Feb 01;11(2):. (PMID: 36838334)
Biomed Res Int. 2021 Apr 30;2021:5572252. (PMID: 33997013)
Oxid Med Cell Longev. 2022 Jun 25;2022:9671594. (PMID: 35795854)
Int J Nanomedicine. 2020 Oct 30;15:8479-8493. (PMID: 33154638)
Sci Rep. 2020 Sep 9;10(1):14851. (PMID: 32908245)
Oxid Med Cell Longev. 2020 Oct 5;2020:1215395. (PMID: 33082906)
Phytother Res. 2020 Aug;34(8):1926-1946. (PMID: 32166813)
Plants (Basel). 2023 Jan 14;12(2):. (PMID: 36679103)
Front Microbiol. 2022 Feb 16;13:820048. (PMID: 35250934)
Nanomaterials (Basel). 2021 Jan 22;11(2):. (PMID: 33499075)
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S1022-S1031. (PMID: 30449178)
SAGE Open Med. 2021 Aug 12;9:20503121211034366. (PMID: 34408877)
Dose Response. 2022 Apr 30;20(1):15593258221088709. (PMID: 35592270)
Sci Rep. 2023 Sep 12;13(1):15048. (PMID: 37700007)
Molecules. 2021 Aug 12;26(16):. (PMID: 34443474)
IET Nanobiotechnol. 2018 Dec;12(8):1009-1017. (PMID: 30964006)
Rev Argent Microbiol. 2019 Apr - Jun;51(2):103-109. (PMID: 30029815)
Biotechnol Adv. 2009 Jan-Feb;27(1):76-83. (PMID: 18854209)
Spectrochim Acta A Mol Biomol Spectrosc. 2015 Mar 15;139:200-5. (PMID: 25561298)
Nat Prod Res. 2015;29(9):857-63. (PMID: 25533422)
J Funct Biomater. 2020 Nov 26;11(4):. (PMID: 33255874)
Nanomedicine. 2016 Apr;12(3):789-799. (PMID: 26724539)
Artif Cells Nanomed Biotechnol. 2018 Feb;46(1):211-222. (PMID: 28612655)
RSC Adv. 2021 Jan 13;11(5):2804-2837. (PMID: 35424248)
Chem Rev. 2014 Aug 13;114(15):7610-30. (PMID: 25003956)
Pharmaceutics. 2022 Feb 04;14(2):. (PMID: 35214093)
Nanomaterials (Basel). 2021 Feb 03;11(2):. (PMID: 33546151)
Biotechnol Lett. 2019 Sep;41(8-9):899-914. (PMID: 31201601)
Colloids Surf B Biointerfaces. 2013 Aug 1;108:80-4. (PMID: 23537829)
Molecules. 2021 Aug 17;26(16):. (PMID: 34443574)
Nanomaterials (Basel). 2021 Aug 17;11(8):. (PMID: 34443916)
Sci Rep. 2021 Jul 15;11(1):14566. (PMID: 34267298)
Toxicol Rep. 2022 May 11;9:1092-1098. (PMID: 36518440)
Nanomaterials (Basel). 2022 Jan 30;12(3):. (PMID: 35159838)
معلومات مُعتمدة: Health sector's laboratory resources King Abdulaziz City for Science and Technology
فهرسة مساهمة: Keywords: Jacobaea maritima; antibacterial; anticancer; green synthesis; silver nanoparticles
المشرفين على المادة: 3M4G523W1G (Silver)
0 (Anti-Bacterial Agents)
0 (Plant Extracts)
تواريخ الأحداث: Date Created: 20231125 Date Completed: 20231127 Latest Revision: 20231127
رمز التحديث: 20231128
مُعرف محوري في PubMed: PMC10671674
DOI: 10.3390/ijms242216512
PMID: 38003704
قاعدة البيانات: MEDLINE
الوصف
تدمد:1422-0067
DOI:10.3390/ijms242216512